Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Cash flows from operating activities:
Net loss	$ (4,021,000)	$ (7,667,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	659,000	667,000
Stock based compensation expense	304,000	$ 676,000
Amortization of debt discount and issue costs	62,000
Change in fair value of derivative obligation	(3,606,000)
Loss on cashless exercise of warrants	564,000
Net change in operating assets and liabilities:
Accounts receivable	1,634,000	$ 114,000
Inventories	568,000	157,000
Prepaid expenses and other current assets	$ (299,000)	(83,000)
Other assets		5,000
Accounts payable	$ (626,000)	(404,000)
Accrued payroll and related expenses	(243,000)	361,000
Deferred revenue	(322,000)	(181,000)
Other liabilities	832,000	486,000
Net cash used in operating activities	(4,494,000)	(5,869,000)
Cash flows from investing activities:
Capital expenditures	(602,000)	(455,000)
Net cash used in investing activities	(602,000)	$ (455,000)
Cash flows from financing activities:
Proceeds from convertible debentures, net of financing costs	4,720,000
Payments on capital lease obligations	(27,000)	$ (16,000)
Repurchase of common stock	(5,000)	(80,000)
Net cash provided by (used in) financing activities	4,688,000	(96,000)
Effects of foreign currency rate changes on cash and cash equivalents	(7,000)	(34,000)
Net decrease in cash and cash equivalents	(415,000)	(6,454,000)
Cash and cash equivalents at beginning of period	3,357,000	14,811,000
Cash and cash equivalents at end of period	2,942,000	$ 8,357,000
Supplemental non-cash financing and investing information:
Derivative obligation related to issuance of warrants	4,282,000
Transfer of inventories to equipment	18,000	$ 218,000
Reclassification of derivative liability to equity	$ 33,000
Equipment acquired by capital lease		$ 112,000